Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hepatitis B virus surface antigen monoclonal antibody and its application

A hepatitis B virus and monoclonal antibody technology, applied in the field of immunology, can solve the problems of difficulty in obtaining human hepatitis B surface antibodies, and achieve good virus-specific effects

Active Publication Date: 2018-07-03
SINOVAC RES & DEV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Since the detection system of human hepatitis B surface antibody is mostly used in the detection of hepatitis B surface antigen at present, and it is difficult to obtain human hepatitis B surface antibody, it is necessary to obtain a hepatitis B surface antibody that is relatively easy to obtain and has a high yield. surface antibody to replace

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hepatitis B virus surface antigen monoclonal antibody and its application
  • Hepatitis B virus surface antigen monoclonal antibody and its application
  • Hepatitis B virus surface antigen monoclonal antibody and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1 immunogen preparation and animal immunization

[0031] (1) The p5GK3 plasmid was constructed by molecular cloning technology, and the uracil synthase (orotidine-5-phosphate decarboxylase) gene Ura3 of Hansenula was knocked out by electrotransformation to obtain the corresponding uracil deficiency After the Hansenula strains were selected, the constructed uracil-auxotrophic Hansenula strains were screened through the auxotrophic medium. The HBsAg expression plasmid pDKXMPHT was constructed by molecular cloning technology, transformed into uracil auxotrophic Hansenula, and the Hansenula strains capable of expressing recombinant HBsAg were screened.

[0032] (2) Take the recombinant Hansenula working seed batch bacterial strain expressing the surface antigen of hepatitis B virus constructed by DNA recombination technology, carry out three-stage fermentation through Erlenmeyer flask, seed tank and production tank, and harvest the bacteria.

[0033] (3) Break u...

Embodiment 2

[0039] Example 2 Cell Fusion and Strain Construction

[0040] (1) Resuscitate and culture the SP2 / 0 cell line before cell fusion, expand the culture 3 days before fusion, remove RPMI1640 cell culture medium (Gibco) 1 day before fusion, and add culture medium again to prepare SP2 / 0 cells.

[0041] (2) The immunized mice were sacrificed, and the mouse splenocyte suspension was prepared according to conventional methods.

[0042] (3) Add an appropriate amount of incomplete IMDM culture medium (Gibco) according to the counting results of splenocytes and SP2 / 0 cells, shake and mix the SP2 / 0 cells, and pipette the splenocytes evenly. Then the splenocytes and SP2 / 0 cells were combined at a ratio of 1:2 in a 50ml centrifuge tube and mixed.

[0043] (4) Add incomplete IMDM culture medium to 50ml, centrifuge for 5 minutes, and pour out the supernatant. Lightly tap the bottom of the fusion tube to loosen and evenly precipitate the cells, and place the centrifuge tube in a 37°C water ba...

Embodiment 3

[0050] Example 3 Monoclonal Antibody Cell Line Ascites Preparation and Antibody Titer Detection

[0051] Resuscitate the frozen hybridoma cells obtained in Example 2 according to conventional methods, and cultivate them. When the cells cover more than 50% of the bottom of the 25ml cell culture bottle, BALB / c mice can be inoculated intraperitoneally according to conventional methods, and the ascites can be collected regularly. HBV-1.

[0052] The hepatitis B vaccine stock solution is diluted with 0.01M PBS1:60, 100 μl / well is coated with an enzyme-labeled plate, overnight at 4°C, and the antibody titer of the hepatitis B virus surface antibody ascites HBV-1 secreted by the hybridoma cells of the present invention is detected, and the antibody is detected OD value / negative serum test OD value (calculated as 0.05 if less than 0.05) is greater than or equal to 2.1, the antibody result is positive, and the dilution factor corresponding to the antibody at this time is the antibody t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a hepatitis B virus surface antigen monoclonal antibody and application thereof, belonging to the field of immunology. In the present invention, after the hepatitis B virus surface antigen is immunized into mice, the mouse spleen cells are fused with the mouse myeloma cells, and the hybridoma cell line SVAHBV-1 that can stably secrete the hepatitis B virus surface antigen monoclonal antibody is screened, and its deposit number is SVAHBV-1. It is CGMCC No.10320, the titer of the monoclonal antibody it secretes is high, up to 106, it can specifically distinguish a variety of common viruses, with good specificity, it can be used for the preparation of hepatitis B virus surface antigen content detection kits and antibodies The detection kit can also be used for differential diagnosis of hepatitis B virus surface antigen, and has wide application prospects and market value.

Description

technical field [0001] The present invention relates to the field of immunology and vaccinology, in particular to an anti-hepatitis B virus surface antigen monoclonal antibody, a hybridoma cell line producing the antibody and the application of the antibody. Background technique [0002] Hepatitis B virus (Hepatitis B Virus, HBV) is a hepatotropic virus and a DNA retrovirus of the hepatovirus family. It was discovered by Dana in 1965 and is called Dan-style particles. It mainly exists in liver cells and damages liver cells. The pathogen can infect the body through blood, mother to child and sexual transmission, causing liver cell inflammation, necrosis, fibrosis, damage to the liver, and triggering viral hepatitis B disease, referred to as hepatitis B. There are two types of hepatitis B: acute and chronic. Acute hepatitis B can be cured in 90% of adults, while chronic hepatitis B has different manifestations, including chronic hepatitis B carriers, chronic active hepatitis ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/20C07K16/08G01N33/68G01N33/577G01N33/569A61K39/42A61P31/20A61P1/16
Inventor 赵冉张立志邹烨宁张星星董高峰童钦蔡芳高强尹卫东
Owner SINOVAC RES & DEV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com